Related Articles
Clinical utility of PDSS2 expression to stratify patients at risk for recurrence of hepatocellular carcinoma
B‑cell translocation gene 1 serves as a novel prognostic indicator of hepatocellular carcinoma
Downregulation of DENND2D by promoter hypermethylation is associated with early recurrence of hepatocellular carcinoma
Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma
Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation